CoreWeave shares have dropped 27.22% over six months and trade at $80.26, even as its backlog reached about $104 billion and second-quarter revenue rose 112.3% to $2.58 billion. The net loss widened to $626 million from $290 million as interest expense climbed to $640 million, and free cash flow was negative $5.74 billion after $6.42 billion of capex. Operating cash flow turned positive at $679 million, and adjusted EBITDA reached $1.51 billion at a 59% margin. Rosenblatt's $250 target contrasts with an average target of $141.47, and 31 of 42 analysts rate the stock Buy, though the article flags a debt-to-equity ratio of 8.94 and a securities fraud class action. It concludes that the setup leans carefully positive, since the backlog is real but rising interest costs leave little room for error.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Get briefings and signals on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the morning, midday and evening briefing of each market and important news as it happens.